What is King Pharmaceuticals's premiums receivable?

King Pharmaceuticals (KG) reported premiums receivable of $297K in Q1 2026.

What does premiums receivable mean?

This represents the total amount of insurance premiums billed to policyholders that remain uncollected at the reporting date. It is a critical indicator of the company's ability to convert written business into actual cash flow. High levels relative to total premiums may signal potential collection issues or changes in payment terms offered to customers.

King Pharmaceuticals KG Premiums receivable

Premiums receivable at other companies

Arch Capital GroupACGL

$6.53B-1.2%

Everest GroupEG

$5.58B-0.7%

SiriusPointSPNT

$2.42B+8.0%

Skyward Specialty Insurance Group, Inc.SKWD

$830.51M+98.9%

Selective Insurance GroupSIGI

$1.58B+2.8%

Universal Insurance HoldingsUVE

$75.96M+5.7%

Segments

By segment

See full

Legacy Reinsurance$297K—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsReceivableAtCarryingValue.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's premiums receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's premiums receivable?: King Pharmaceuticals (KG) reported premiums receivable of $297K in Q1 2026.
What does premiums receivable mean?: This represents the total amount of insurance premiums billed to policyholders that remain uncollected at the reporting date. It is a critical indicator of the company's ability to convert written business into actual cash flow. High levels relative to total premiums may signal potential collection issues or changes in payment terms offered to customers.